Literature DB >> 17005729

Tumors reveal their secrets to cytotoxic T cells.

Nicholas A Williamson1, Jamie Rossjohn, Anthony W Purcell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17005729      PMCID： PMC1595405          DOI： 10.1073/pnas.0606951103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  13 in total

Review 1.  Dissecting the role of peptides in the immune response: theory, practice and the application to vaccine design.

Authors:  Anthony W Purcell; Weiguang Zeng; Nicole A Mifsud; Lauren K Ely; Whitney A Macdonald; David C Jackson
Journal:  J Pept Sci       Date:  2003-05       Impact factor: 1.905

2.  Analysis of protein phosphorylation by mass spectrometry.

Authors:  Benjamin A Garcia; Jeffrey Shabanowitz; Donald F Hunt
Journal:  Methods       Date:  2005-01-13       Impact factor: 3.608

3.  Crystallography & NMR system: A new software suite for macromolecular structure determination.

Authors:  A T Brünger; P D Adams; G M Clore; W L DeLano; P Gros; R W Grosse-Kunstleve; J S Jiang; J Kuszewski; M Nilges; N S Pannu; R J Read; L M Rice; T Simonson; G L Warren
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1998-09-01

4.  Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy.

Authors:  Angela L Zarling; Joy M Polefrone; Anne M Evans; Leann M Mikesh; Jeffrey Shabanowitz; Sarah T Lewis; Victor H Engelhard; Donald F Hunt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-25       Impact factor: 11.205

Review 5.  Adoptive immunotherapy for EBV-associated malignancies.

Authors:  Stephen Gottschalk; Helen E Heslop; Cliona M Rooney
Journal:  Leuk Lymphoma       Date:  2005-01

6.  Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue.

Authors:  Andrew I Webb; Michelle A Dunstone; Weisan Chen; Marie-Isabel Aguilar; Qiyuan Chen; Heather Jackson; Linus Chang; Lars Kjer-Nielsen; Travis Beddoe; James McCluskey; Jamie Rossjohn; Anthony W Purcell
Journal:  J Biol Chem       Date:  2004-03-05       Impact factor: 5.157

Review 7.  Cancer/testis antigens: an expanding family of targets for cancer immunotherapy.

Authors:  Matthew J Scanlan; Ali O Gure; Achim A Jungbluth; Lloyd J Old; Yao-Tseng Chen
Journal:  Immunol Rev       Date:  2002-10       Impact factor: 12.988

Review 8.  The immunobiology of cancer immunosurveillance and immunoediting.

Authors:  Gavin P Dunn; Lloyd J Old; Robert D Schreiber
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

9.  Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines.

Authors:  J I Mayordomo; D J Loftus; H Sakamoto; C M De Cesare; P M Appasamy; M T Lotze; W J Storkus; E Appella; A B DeLeo
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

10.  Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo.

Authors:  A L Zarling; S B Ficarro; F M White; J Shabanowitz; D F Hunt; V H Engelhard
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307
View more
  4 in total

1.  MHC-restricted phosphopeptides from insulin receptor substrate-2 and CDC25b offer broad-based immunotherapeutic agents for cancer.

Authors:  Angela L Zarling; Rebecca C Obeng; A Nicole Desch; Joel Pinczewski; Kara L Cummings; Donna H Deacon; Mark Conaway; Craig L Slingluff; Victor H Engelhard
Journal:  Cancer Res       Date:  2014-10-08       Impact factor: 12.701

2.  Structural basis for the presentation of tumor-associated MHC class II-restricted phosphopeptides to CD4+ T cells.

Authors:  Yili Li; Florence R Depontieu; John Sidney; Theresa M Salay; Victor H Engelhard; Donald F Hunt; Alessandro Sette; Suzanne L Topalian; Roy A Mariuzza
Journal:  J Mol Biol       Date:  2010-04-24       Impact factor: 5.469

3.  Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopes.

Authors:  Jan Petersen; Stephanie J Wurzbacher; Nicholas A Williamson; Sri H Ramarathinam; Hugh H Reid; Ashish K N Nair; Anne Y Zhao; Roza Nastovska; Geordie Rudge; Jamie Rossjohn; Anthony W Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-05       Impact factor: 11.205

4.  The pituitary tumor transforming gene 1 (PTTG-1): an immunological target for multiple myeloma.

Authors:  Maurizio Chiriva-Internati; Raffaele Ferrari; Madhavi Prabhakar; Yuefei Yu; Luigi Baggoni; Jorge Moreno; Nicoletta Gagliano; Nicola Portinaro; Marjorie R Jenkins; Eldo E Frezza; Fred Hardwicke; Nicholas D'Cunha; Wmartin Kast; Everardo Cobos
Journal:  J Transl Med       Date:  2008-04-02       Impact factor: 5.531
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.